ResearcherUniversity Hospitals of ClevelandNo recent work listed
Jennifer Anne Dorth
Matched on ORCID iD 0000-0002-1112-3781; OpenAlex author ID A5011105999. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 1 trial · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 4
- Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreati… Co-author DOI 10.1016/j.hpb.2021.08.938↗
- Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagen… First author DOI 10.1177/00031348211038581↗
- Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions. Co-author DOI 10.1586/14737140.2016.1168698↗
- The role of neoadjuvant therapy in pancreatic cancer: a review. Last author DOI 10.2217/fon.15.335↗
Trials 1
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- John Brian Ammori · 3 shared papers, 2016–2022 · strength 0.35
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Paper The role of neoadjuvant therapy in pancreatic cancer: a review. DOI 10.2217/fon.15.335↗
- Luke Daniel Rothermel · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Jonathan J. Hue · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Kavin Sugumar · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- David Lawrence Bajor · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Lee Mayer Ocuin · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Jeffrey M. Hardacre · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Jordan Michael Winter · 2 shared papers, 2021–2022 · strength 0.26
- Paper Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-op… DOI 10.1016/j.hpb.2021.08.938↗
- Paper Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreat… DOI 10.1177/00031348211038581↗
- Suzanne M. Russo · 2 shared papers, 2016 · strength 0.14
- Jennifer Rachel Eads · 1 shared paper, 2016 · strength 0.08
- Rodney J. Ellis · 1 shared paper, 2016 · strength 0.05
- Lauren M. Rosati · 1 shared paper, 2016 · strength 0.05
- Simon Shek-Man Lo · 1 shared paper, 2016 · strength 0.05
- Sten D. Myrehaug · 1 shared paper, 2016 · strength 0.05
- Joseph M. Herman · 1 shared paper, 2016 · strength 0.05
- Bin Sing Teh · 1 shared paper, 2016 · strength 0.05
- William C. Small · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.